Company: SCLXW
Filing Date: 2025-07-23
Form Type: 8-K
Source: 0001193125-25-162969
Chunk: 0

Company: Scilex Holding Co
Filing Date: 2025-07-23
Form: 8-K
Item: Item 9.01
Chunk 0
---
Item 9.01.      Financial Statements and Exhibits.  

(d) Exhibits.

  Exhibit      Description                                                                                                                                                                         
   Number                                                                                                                                                                                          
      2.1      Amendment No. 2 to Agreement and Plan of Merger, dated as of July 22, 2025, by and among Denali Capital Acquisition Corp., Denali Merger Sub Inc. and Semnur Pharmaceuticals, Inc.  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).                                                                               

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  SCILEX HOLDING COMPANY                                           
  By:                         /s/ Jaisim Shah                      
  Name:                       Jaisim Shah                          
  Title:                      Chief Executive Officer & President  

Date: July 23, 2025